Dopamine D2 receptor agonists: an analysis of indirect models

Area of Science:

• Medicinal Chemistry
• Neuropharmacology
• Computational Chemistry

Background:

• A dopamine (DA) D2 receptor agonist pharmacophore model was previously proposed.
• Understanding ligand-receptor interactions is crucial for drug development.

Purpose of the Study:

• To synthesize and evaluate N-propyl aminotetralin derivatives for their affinity to dopamine D2 receptors.
• To validate a proposed pharmacophore model for DA D2 receptor agonists.
• To investigate the impact of methyl substitutions on receptor binding.

Main Methods:

• Synthesis of N-propyl derivatives: (1S,2S)-5-hydroxy-1-methyl-2-propylaminotetralin and trans-(+/-)-5-hydroxy-3-methyl-2-propylaminotetralin.
• Conformational analysis using molecular mechanics calculations.
• Radioligand binding assays using [3H]spiroperidol and [3H]N-propylnorapomorphine to determine receptor affinity.

Main Results:

• Synthesized N-propyl derivatives adopted pharmacophore conformations more readily than N,N-dipropyl analogs.
• These N-propyl derivatives exhibited higher affinity for striatal DA D2 receptors.
• The proposed pharmacophore model for C5-oxygenated 2-aminotetralins appears accurate.
• Comparison of superposition modes for 5- and 7-hydroxylated regioisomers revealed differences in methyl group positioning, indicating limitations in predicting tolerance to bulk.

Conclusions:

• The study supports the accuracy of the proposed dopamine D2 receptor agonist pharmacophore model for C5-oxygenated 2-aminotetralins.
• The findings highlight that receptor binding site tolerance for steric bulk is complex and not solely dependent on the acceptance of smaller groups.
• A definitive mode of superposition for regioisomers cannot be established without a more defined understanding of the receptor binding site.